🔗 Share this article

A shadow market for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.

Investigational Drug Acquiring Popularity Via Social Media

Retatrutide, which is still in clinical trials, is being promoted by online personalities for its supposed weight-reducing effects. Followers are encouraged to contact these profiles directly for supplier links, while also obtaining discount codes.

Active Commerce on Messaging Platforms

Additionally, a robust market exists on Telegram, where groups with numerous of members share comparison photos, injection guides and assertions of rapid UK delivery. Vendors market the substance there before directing customers to other platforms for purchases.

Understanding The Experimental Drug

This medication is an investigational injection developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could help individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.

Healthcare Professionals Express Concerns

However, doctors and pharmacists have cautions that the distribution of what is still an unlicensed medication in the UK is worrisome and could result in individuals administering products of unknown origin.

Some experts stated the popularity for the experimental drug could be linked to the rising price of approved weight loss treatments such as Mounjaro.

Legal Status and Implementation

Marketing the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that cannot be marketed or distributed for personal consumption under the British medical regulations.

Several content creators try to circumvent the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still violate pharmaceutical, advertising, and customer regulations, potentially leading to fines, legal action or imprisonment.

Service Response and Material Removal

According to TikTok, the platform has removed violative content and prohibited associated keywords and query recommendations. The company said it was dedicated to maintaining the service secure and allocating resources in strengthening enforcement strategies.

Online Marketplace Operations

Investigations also found communities with up to 9,000 participants selling the experimental drug using Telegram's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” immediately brings up channels with numerous of members, populated with photos of slimming results, positive testimonials and detailed guides for mixing or injecting at home.

After minutes of joining one group, a seller shared WhatsApp details, where most purchases take place. The seller provided an instruction manual and promised shipping within 48 hours. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one asked about weight, health issues or past usage.

Product Details and Costs

Inside these communities, posts display black plastic parcels with Royal Mail stickers, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at home with sterile water, or pre-filled injectors typically sold at £160 for 20mg. When questioned how long a injector should last, sellers give conflicting answers ranging from a few weeks to “depends on your body”.

Service Moderation and Safety Measures

A representative for Telegram stated it actively moderated dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are injecting substances they can’t verify. Even if the research behind this drug is sound, these online versions may not contain what they claim,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.

A medical professional of an online medical service linked the increase in interest to recent price rises for approved slimming drugs such as Mounjaro. “With costs rising, individuals are using online platforms. But counterfeit injections are extremely risky. You cannot know what’s inside or whether the environment they were produced in was sterile,” she said.

Her team has previously encountered individuals injured by personal administration from unverified suppliers. “We recognize the frustration, but buying from Telegram or WhatsApp is taking chances with your health,” said the doctor. “These materials could be impure or improperly measured.”

Producer Statement

A spokesperson from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for human use,” they said, noting that any item “falsely representing itself as a Lilly investigational substance not yet authorized … may subject patients to potentially significant health risks”.